Europe Pricing Market Research Reports - Data on Pricing in Europe page 1

Printer Format

Region:	All Regions > Europe
Category:	All Categories > Life Sciences > Pharmaceuticals > Pricing

(57 reports matching your criteria)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France 5/15/2013 \| published by: GlobalData ... information and an analysis on the healthcare, regulatory and reimbursement landscape of France. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure ... \| read more...	$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy 5/15/2013 \| published by: GlobalData ... information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure. Most ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Austria 3/31/2013 \| published by: GlobalData ... regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Finland 3/31/2013 \| published by: GlobalData ... healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Norway 3/31/2013 \| published by: GlobalData ... analysis regarding the healthcare, regulatory, and reimbursement landscape in Norway. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure. Most importantly, it ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Portugal 3/31/2013 \| published by: GlobalData ... and analysis of the healthcare, regulatory, and reimbursement landscape in Portugal. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, as well as the healthcare infrastructure. ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Switzerland 2/15/2013 \| published by: GlobalData ... regarding the healthcare, regulatory, and reimbursement landscape in Switzerland. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the country’s healthcare infrastructure. Most importantly, it ... \| read more...	$1,995.00
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide 2/1/2013 \| published by: JustPharmaReports.com ... usually at launch - about the product’s value (clinical- and cost-effectiveness), budget impact and/or utilisation to optimise performance, whilst at the same time allowing patient access. For many products considered costly they are almost essential ... \| read more...	$1,050.00
Italy: Market Access Tracker 11/29/2012 \| published by: Decision Resources ... years ($16.2 billion in 2011) and is steadily sliding down the global rankings. The relative decline of the Italian market reflects the government’s increasingly stringent cost-containment strategy. Faced with crippling debt, the Italian government has ... \| read more...	$4,000.00
Europe: Market Access Tracker 11/14/2012 \| published by: Decision Resources ... the United Kingdom. Timely analysis of key events, regular webinar update presentations, and access to our team of experts will equip biopharmaceutical companies with the insight needed to evaluate the implications of the latest changes ... \| read more...	$4,000.00
Conference Documentation: European Pharmaceutical Pricing & Reimbursement 10/29/2012 \| published by: SMI Publishing, Ltd ... and market access fields. Focusing on the development of novel pricing and market access strategies, this informative conference will bring together key opinion leaders in the field to provide attendees with an in depth look ... \| read more...	$788.78
United Kingdom: Market Access Tracker 10/1/2012 \| published by: Decision Resources ... launch delays, a relatively liberal regulatory environment, and a strong R&D base made the United Kingdom one of the most attractive markets in Europe for the research-based pharmaceutical industry. However, the commercial environment for manufacturers ... \| read more...	$4,000.00
Spain: Market Access Tracker 9/18/2012 \| published by: Decision Resources ... uptake of new drugs than the other major European pharmaceutical markets. However, the Spanish market presents some significant challenges for pharmaceutical companies: prices are among the lowest in Europe, and the Spanish government has imposed ... \| read more...	$4,000.00
Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity 7/10/2012 \| published by: GBI Research ... Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity” provides detailed insight into the Europe API market. ... \| read more...	$3,500.00
Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing 7/10/2012 \| published by: GBI Research ... Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical supply chain ... \| read more...	$3,500.00
Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs 5/18/2012 \| published by: GBI Research ... released its latest research “Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs”. It provides a comprehensive overview ... \| read more...	$3,500.00
The Pharmaceutical Market: Poland 5/15/2012 \| published by: Espicom Healthcare Intelligence ... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ... \| read more...	$1,085.00
The Pharmaceutical Market: Germany 5/14/2012 \| published by: Espicom Healthcare Intelligence ... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ... \| read more...	$1,085.00
The Pharmaceutical Market: Croatia 5/14/2012 \| published by: Espicom Healthcare Intelligence ... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ... \| read more...	$1,085.00
The Pharmaceutical Market: Slovenia (pdf/xls) 2/17/2012 \| published by: Espicom Healthcare Intelligence ... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ... \| read more...	$1,085.00
The Pharmaceutical Market: UK (pdf/xls) 2/17/2012 \| published by: Espicom Healthcare Intelligence ... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ... \| read more...	$1,085.00
The Pharmaceutical Market: Czech Republic (pdf/xls) 2/17/2012 \| published by: Espicom Healthcare Intelligence ... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ... \| read more...	$1,085.00
The Outlook for Pharmaceuticals in Northern Europe (pdf/xls) 2/17/2012 \| published by: Espicom Healthcare Intelligence The Northern European countries are projected to represent a combined pharmaceutical market value of over US$26 billion at retail prices by 2016. \| read more...	$3,630.00
The Outlook for Pharmaceuticals in Central & Eastern Europe (pdf/xls) 2/17/2012 \| published by: Espicom Healthcare Intelligence ... expected to reach US$104.2 billion by 2016. The market is expected to expand by a moderate CAGR in US dollar terms between 2011 and 2016, as the region’s economies recover from the global economic crisis. \| read more...	$3,630.00
The Pharmaceutical Market: Austria (pdf/xls) 2/17/2012 \| published by: Espicom Healthcare Intelligence ... provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population ... \| read more...	$1,085.00

< prev 1 2 3 next >